Features of the use of probiotics for antibiotic-associated diarrhea in children

Authors

  • S.L. Nyankovskyy Danylo Halytsky Lviv National Medical University, Lviv, Ukraine http://orcid.org/0000-0002-0658-9253
  • О.S. Nyankovska Danylo Halytsky Lviv National Medical University, Lviv, Ukraine http://orcid.org/0000-0002-7683-9588
  • M.S. Yatsula Danylo Halytsky Lviv National Medical University, Lviv, Ukraine http://orcid.org/0000-0002-3733-4907
  • M.I. Horodylovska Danylo Halytsky Lviv National Medical University, Lviv, Ukraine http://orcid.org/0000-0003-4962-3455
  • Ya.V. Tomkiv Municipal Nonprofit Organization “Lviv City Children’s Clinical Hospital”, Lviv, Ukraine
  • H.Z. Vivcharivska Municipal Nonprofit Organization “Lviv City Children’s Clinical Hospital”, Lviv, Ukraine
  • V.D. Shaidych Municipal Nonprofit Organization “Lviv City Children’s Clinical Hospital”, Lviv, Ukraine
  • O.M. Horayska Municipal Nonprofit Organization “Lviv City Children’s Clinical Hospital”, Lviv, Ukraine
  • L.V. Zastavna Municipal Nonprofit Organization “Lviv City Children’s Clinical Hospital”, Lviv, Ukraine
  • Z.V. Tomkiv Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

DOI:

https://doi.org/10.22141/2224-0551.15.2.2020.200272

Keywords:

antibiotic-associated diarrhea, Lactobacillus rhamnosus GG, dysbiosis, Candida, bifidobacteria, lactobacilli, Probiolog Baby, children

Abstract

Antibiotic-associated diarrhea arises when the antibio­tic disrupts the ecology of the intestinal microbiota, by altering the diversity and number of bacteria in the gut. These changes can affect the capacity of the resident microbiota to resist the invasion of pathogenic microorganisms or the overgrowth of opportunistic pathogens species that are endogenously present in the microbiome. Therefore, antibiotic-associated diarrhea may result in prolonged hospitalization, increased health care costs and other complications. Diarrhea is most frequently associated with the use of broad-spectrum antibiotics. Probiotics are “live microorganisms that, when administered in adequate amounts, confer a health be­nefit on the host”. Numerous clinical researches evaluate the efficacy of Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhea. The aim of our research was to study the efficacy of the probiotic Probiolog Baby in children aged from 4 months to 9 years with antibiotic-associated diarrhea, and to investigate its effect on dysbiotic bowel changes. We observed 28 children aged from 4 months to 9 years (average age 4.6 ± 1.9 years) with antibiotic-associated diarrhea, including 57 % of boys and 43 % of girls. The children received the probiotic Probiolog Baby — 1 stick daily for 10 days. In 10 days, only 2 children (7.2 %) had complaints about diarrhea against 100 % at the beginning of our research. The use of Lactobacillus rhamnosus GG (ATCC 53103) in children with antibiotic-associated diarrhea helps reduce diarrhea, colic, bloating, nausea, vomiting, anxiety and poor sleep in children. Considering the combined effect of Lactobacillus rhamnosus GG strain, it can be argued that Probiolog Baby increases the levels of bifidobacteria and lactobacilli in the stool and also reduces the growth of Candida and pathogenic intestinal flora.

References

Keeney KM, Yurist-Doutsch S, Arrieta MC, Finlay BB. Effects of antibiotics on human microbiota and subsequent disease. Annu Rev Microbiol. 2014;68:217–235. doi:10.1146/annurev-micro-091313-103456.

Francino MP. Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Front Microbiol. 2016;6:1543. doi:10.3389/fmicb.2015.01543.

Sarker P, Mily A, Mamun AA, et al. Ciprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon Epithelia. Antibiotics (Basel). 2014;3(3):353–374. doi:10.3390/antibiotics3030353.

Croswell A, Amir E, Teggatz P, Barman M, Salzman NH. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect Immun. 2009;77(7):2741–2753. doi:10.1128/IAI.00006-09.

Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007;1(1):56–66. doi:10.1038/ismej.2007.3.

Turck D, Bernet JP, Marx J, et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr. 2003;37(1):22–26. doi:10.1097/00005176-200307000-00004.

Wiström J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2001;47(1):43–50. doi:10.1093/jac/47.1.43.

Kramer MS, Hutchinson TA, Naimark L, Contardi R, Flegel KM, Leduc DG. Antibiotic-associated gastrointestinal symptoms in general pediatric outpatients. Pediatrics. 1985;76(3):365–370.

Agamennone V, Krul CAM, Rijkers G, Kort R. A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands. BMC Gastroenterol. 2018;18(1):103. doi:10.1186/s12876-018-0831-x.

McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16(18):2202–2222. doi:10.3748/wjg.v16.i18.2202.

Wiström J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2001;47(1):43–50. doi:10.1093/jac/47.1.43.

Coté GA, Buchman AL. Antibiotic-associated diarrhoea. Expert Opin Drug Saf. 2006;5(3):361–372. doi:10.1517/14740338.5.3.361.

Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med. 2002;162(19):2177–2184. doi:10.1001/archinte.162.19.2177.

Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015;42(10):1149–1157. doi:10.1111/apt.13404.

Surawicz CM. Antibiotic-associated diarrhea in children: how many dirty diapers?. J Pediatr Gastroenterol Nutr. 2003;37(1):2–3. doi:10.1097/00005176-200307000-00002.

Food and Agriculture Organization of the United Nations; World Health Organization. Probiotics in food: health and nutritional properties and guidelines for evaluation. Rome: Food and Agriculture Organization of the United Nations: World Health Organization; 2006. 50p.

Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi:10.1038/nrgastro.2014.66.

Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One. 2012;7(4):e34938. doi:10.1371/journal.pone.0034938.

Lee YK, Puong KY, Ouwehand AC, Salminen S. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J Med Microbiol. 2003;52(Pt 10):925–930. doi:10.1099/jmm.0.05009-0.

von Ossowski I, Reunanen J, Satokari R, et al. Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Appl Environ Microbiol. 2010;76(7):2049–2057. doi:10.1128/AEM.01958-09.

Collado MC, González A, González R, Hernández M, Ferrús MA, Sanz Y. Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori. Int J Antimicrob Agents. 2005;25(5):385–391. doi:10.1016/j.ijantimicag.2005.01.017.

Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol. 2005;3(10):777–788. doi:10.1038/nrmicro1273.

Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004;28(4):405–440. doi:10.1016/j.femsre.2004.01.003.

Ashraf R, Shah NP. Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr. 2014;54(7):938–956. doi:10.1080/10408398.2011.619671.

Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019;4(4):CD004827. Published 2019 Apr 30. doi:10.1002/14651858.CD004827.pub5.

Floch MH, Ringel Y, Walker WA. The Microbiota in Gastrointestinal Pathophysiology. Implications for Human Health, Prebiotics, Probiotics, and Dysbiosis. Elsevier Inc.; 2017. 442p.

Hawrelak JA, Whitten DL, Myers SP. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review. Digestion. 2005;72(1):51–56. doi:10.1159/000087637.

Yan F, Polk DB. Lactobacillus rhamnosus GG: An Updated Strategy to Use Microbial Products to Promote Health. Funct Food Rev. 2012;4(2):77–84.

Lu R, Fasano S, Madayiputhiya N, Morin NP, Nataro J, Fasano A. Isolation, identification, and characterization of small bioactive peptides from Lactobacillus GG conditional media that exert both anti-Gram-negative and Gram-positive bactericidal activity. J Pediatr Gastroenterol Nutr. 2009;49(1):23–30. doi:10.1097/MPG.0b013e3181924d1e.

Downloads

Published

2020-03-01

Issue

Vol. 15 No. 2 (2020)

Section

Clinical Pediatrics

License

Copyright (c) 2020 S.L. Nyankovskyy, О.S. Nyankovska, M.S. Yatsula, M.I. Horodylovska, Ya.V. Tomkiv, H.Z. Vivcharivska, V.D. Shaidych, O.M. Horayska, L.V. Zastavna, Z.V. Tomkiv

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

  1. The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
  2. Directing  the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
  3. The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
  4. The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
  5. The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
  6. The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
  7. The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.